Anbio Biotechnology (NASDAQ:NNNN) Sees Unusually-High Trading Volume – Still a Buy?

Shares of Anbio Biotechnology (NASDAQ:NNNN) saw unusually-strong trading volume on Tuesday . 218,119 shares traded hands during mid-day trading, an increase of 233% from the previous session’s volume of 65,521 shares.The stock last traded at $6.4710 and had previously closed at $6.54.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Anbio Biotechnology has a consensus rating of “Sell”.

Anbio Biotechnology Price Performance

The firm has a 50-day moving average of $9.24 and a 200-day moving average of $18.98.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.